OA14.03 Six-year Survival and HRQoL Outcomes with 1L Nivolumab + Ipilimumab in Patients with Metastatic NSCLC from CheckMate227

S.S. Ramalingam, T-E. Ciuleanu, R. Bernabe, Makoto Nishio, H. Mizutani, J.-S. Lee, C. Audigier-Valette, Randeep Sangha, László Urbán, J.A. Burgers, A. Pluzanski, Ki Hyeong Lee, B. Zurawski, M. Schenker, Solange Peters, Luis Paz‐Ares, H. Borghaei, K.J. O’Byrne, J.R. Brahmer, R.G. Gupta, Judith Bushong, Li Li, Yong Yuan, Steven I. Blum, Martin Reck